SCHEMBL16736751

SCHEMBL16736751

CC(C)c1cc(O)c(C(C)(C)C)cc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 5/20 0.52
ALDH1A1 P00352 5/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
KDM4E B2RXH2 1/20 0.52
CYP1A2 P05177 1/20 0.52
MAPT P10636 1/20 0.52
ATP2A2 P16615 1/20 0.52
ATP2A3 Q93084 1/20 0.52
LMNA P02545 4/20 0.44
GABRA1 P14867 3/20 0.41
GABRB1 P18505 1/20 0.41
TP53 P04637 4/20 0.40
CYP2C9 P11712 3/20 0.40
CYP2C19 P33261 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2D6 P10635 1/20 0.40
HPGD P15428 1/20 0.40
HIF1A Q16665 2/20 0.40
TYR P14679 2/20 0.39
NR1I2 O75469 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16117697 0.92 ALOX15 (0.52) ALOX15ALDH1A1SMN1; SMN2KDM4ECYP1A2
SCHEMBL16736892 0.83 LMNA (0.47) ALOX15ALDH1A1SMN1; SMN2KDM4ECYP1A2
SCHEMBL16736760 0.82 RORC (0.46) ALOX15ALDH1A1SMN1; SMN2KDM4ECYP1A2
SCHEMBL8209720 0.82 ALOX15 (0.58) ALOX15ALDH1A1SMN1; SMN2KDM4ECYP1A2
SCHEMBL12393857 0.82 ALOX15 (0.65) ALOX15ALDH1A1SMN1; SMN2KDM4ECYP1A2
SCHEMBL15631282 0.79 LMNA (0.54) ALOX15ALDH1A1CYP1A2MAPTLMNA
SCHEMBL16117670 0.79 ALDH1A1 (0.67) ALOX15ALDH1A1SMN1; SMN2KDM4ECYP1A2
SCHEMBL10937876 0.78 ALOX15 (0.54) ALOX15ALDH1A1SMN1; SMN2KDM4ECYP1A2
SCHEMBL10935495 0.78 ALOX15 (0.54) ALOX15ALDH1A1SMN1; SMN2KDM4ECYP1A2
SCHEMBL16736702 0.77 ALOX15 (0.71) ALOX15ALDH1A1SMN1; SMN2KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170174600-A1 2,5-DIALKYL-4-H/HALO/ETHER-PHENOL COMPOUNDS TANSNA THERAPEUTICS, INC. 2017-06-22 US disclosed
US-20170174600-A1 2,5-DIALKYL-4-H/HALO/ETHER-PHENOL COMPOUNDS TANSNA THERAPEUTICS, INC. 2017-06-22 US disclosed
US-9630896-B2 2,5-dialkyl-4-H/halo/ether-phenol compounds TANSNA THERAPEUTICS, INC. (US) 2017-04-25 US disclosed
US-9630896-B2 2,5-dialkyl-4-H/halo/ether-phenol compounds TANSNA THERAPEUTICS, INC. (US) 2017-04-25 US disclosed
US-9630896-B2 2,5-dialkyl-4-H/halo/ether-phenol compounds TANSNA THERAPEUTICS, INC. (US) 2017-04-25 US disclosed
US-20150148430-A1 2,5-DIALKYL-4-H/HALO/ETHER-PHENOL COMPOUNDS TANSNA THERAPEUTICS, INC. 2015-05-28 US disclosed
US-20150148430-A1 2,5-DIALKYL-4-H/HALO/ETHER-PHENOL COMPOUNDS TANSNA THERAPEUTICS, INC. 2015-05-28 US disclosed
US-20150148430-A1 2,5-DIALKYL-4-H/HALO/ETHER-PHENOL COMPOUNDS TANSNA THERAPEUTICS, INC. 2015-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170174600-A1 2,5-DIALKYL-4-H/HALO/ETHER-PHENOL COMPOUNDS COMT, DDT, TYR ALOX15 1851/4885ALDH1A1 852/4885SMN1; SMN2 210/4885
US-20150148430-A1 2,5-DIALKYL-4-H/HALO/ETHER-PHENOL COMPOUNDS COMT, DDT, TYR ALOX15 1851/4885ALDH1A1 852/4885SMN1; SMN2 210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.